RE: Re: Rating reiteration3 Dec 2022 13:04
Hi Phyl,
Trading less these days as I like to be more cautious, but luckily all trades since June have been okay - so far: bought RIO at £48, ULVR twice at £36, LGEN at 209, 214 and 235p, and AAL three times from £27 down to £25. Bought into ULVR because it's another one that's been rather static over the last six years and could not see that situation continuing.
I believe the economic environment in which a company operates is as important as its financial fundamentals.
My only sale since June was GSK (sold for just shy of £18), but that was far more to do with what was happening with the company at the time rather than the economic environment. I'm just as cautious with my sales. Didn't really want the cash - it was earmarked for investment.
However, I'm still about 15 percent in cash at the moment. Not happy with the 1 percent instant access account but that downside is more than offset by the ability to dip into the market occasionally.
The AAL purchases were something I should have done sooner, but I had trouble burying the hatchet over the SXX debacle.